NCT01848548

Brief Summary

Awake tracheal intubation is the standard management for patients as risk for airway compromise. It is also commonly done in cases where there is significant cervical spine pathology i.e. cervical myelopathy or instability. The anesthetic technique used for the awake intubation is crucial to the patient's safety. One of the most important aspects of the anesthetic technique is airway anesthesia prior to placement of an endotracheal tube. The superior laryngeal nerve is responsible for mediating the cough reflex around the vocal cords. The investigators have developed an approach to reliably block the superior laryngeal nerve by injecting local anesthetic near the nerve in a unique approach. Injecting local anesthetic into or through the thyrohyoid membrane will effectively block the superior laryngeal nerve

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
25

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Apr 2013

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 19, 2013

Completed
1 month until next milestone

Study Start

First participant enrolled

April 1, 2013

Completed
1 month until next milestone

First Posted

Study publicly available on registry

May 7, 2013

Completed
4.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2017

Completed
Last Updated

November 6, 2017

Status Verified

November 1, 2017

Enrollment Period

4.3 years

First QC Date

February 19, 2013

Last Update Submit

November 1, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • The primary outcome measure is to assess the efficacy of blocking the superior laryngeal nerve by using cough at the vocal cords on a 4 point scale

    Immediate Perioperative period

Secondary Outcomes (1)

  • Time to placement of block

    Immediate Perioperative Period

Other Outcomes (3)

  • During the intubation the lowest mean arterial blood pressure (MAP)

    Immediate Perioperative Period

  • The lowest heart rate(HR) during intubation

    Immediate Perioperative Period

  • The lowest respiratory rate during the intubation

    Immediate Perioperative Period

Study Arms (1)

Assessment of Superior Laryngeal Nerve Block Technique

Procedure: Superior Laryngeal Nerve Block using the Thyrohyoid Membrane as an Anatomic Landmark

Interventions

The needle is introduced just lateral to midline above the thyroid notch in a slightly medial direction so as to enter the thyrohyoid membrane, and inserted about 1-1.5 cm. Three milliliters of 2% lidocaine is injected.

Assessment of Superior Laryngeal Nerve Block Technique

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Scheduled Surgery Patients who require an awake intubation

You may qualify if:

  • Patients between the ages of 18-80 requiring an awake intubation for endotracheal intubation.
  • Ability to speak and understand English

You may not qualify if:

  • Allergy to lidocaine
  • Emergent operative case
  • Therapeutic anticoagulation
  • Mouth opening less than 2 cm

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Wake Forest Baptist Health

Winston-Salem, North Carolina, 27157, United States

Location

Study Officials

  • Scott Miller, MD

    Wake Forest University Health Sciences

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 19, 2013

First Posted

May 7, 2013

Study Start

April 1, 2013

Primary Completion

July 1, 2017

Study Completion

July 1, 2017

Last Updated

November 6, 2017

Record last verified: 2017-11

Locations